Human Physiology

, Volume 41, Issue 3, pp 328–335 | Cite as

Endotoxin is a component in the pathogenesis of chronic viral diseases

  • I. A. Anikhovskaya
  • A. A. Kubatiev
  • G. R. Khasanova
  • M. Yu. YakovlevEmail author


The level of endotoxin and indicators of the activity of anti-endotoxin immunity (the concentration of antibodies against Re chemotype glycolipid and enterobacterial common antigen) were determined in the serum of 174 patients with persistent viral infections (with herpes simplex, hepatitis C, and human immunodeficiency viruses). In HIV-infected patients, the presence of markers of the systemic inflammatory response syndrome (interleukin IL-1β) and acquired immunodeficiency (CD4+) was also determined. Persistent viral infections have been found to be accompanied by endotoxin aggression of intestinal origin, which they cause themselves and which can induce the systemic inflammatory response syndrome. In HIV-infected patients, this syndrome is cyclic, the phase of hyperactivity alternating with immunodeficiency. Schematically, this process can be represented as the following sequence of events: HIV-mediated damage to the intestinal barrier-development of endotoxin aggression-induction the of systemic inflammatory response syndrome-immune exhaustion, which is transient and related to the duration of the virus replication cycle, i.e., with the damage to enterocytes. The use of the anti-endotoxin component (a tool for reducing the levels of endotoxin in blood) in the scheme of treatment for persistent viral infections can contribute to successful prevention of complications.


lipopolysaccharide endotoxin aggression viral iridocyclitis chronic hepatitis C HIV infection systemic inflammatory response syndrome acquired immunodeficiency syndrome 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Khasanova, G.R., Anokhin, V.A., Urazaev, R.A., and Yakovlev, M.Yu., Endotoxemia and bronchial obstruction syndrome in respiratory viral infections, Kazan. Med. Zh., 1993, no. 1, p. 21.Google Scholar
  2. 2.
    Vyshegurov, Ya.Kh., Anikhovskaya, I.A., Rascheskov, A.Yu., et al., Etiology of Endotoxin Aggression and Its Role as an Obligate Pathogenetic Factor in Iridocyclites of Different Origins, Hum. Physiol., 2006, vol. 32, no. 6, p. 726.CrossRefGoogle Scholar
  3. 3.
    Hanashiro, R., Fujino, K., Gugunfu, Y., et al., Synthetic lipid A-induced uveitis and endotoxin-induced uveitis-comparative study, Jpn. J. Ophthalmol., 1997, vol. 41, no. 6, p. 355.CrossRefGoogle Scholar
  4. 4.
    Alikova, T.T., Batmanov, Yu.E., Vyshegurov, Ya.Kh., and Yakovlev, M.Yu., The indices of systemic endotoxemia and the titers of antibacterial antibodies in patients with agnogenic anterior uveitis, Vestn. Ros. Gos. Med. Univ., 2003, vol. 29, no. 3, p. 43.Google Scholar
  5. 5.
    Brenchley, J.M., Price, D.A., Schacker, T.W., et al., Microbial translocation is a cause of systemic immune activation in chronic HIV infection, Nature Med., 2006, no. 12, p. 1365.Google Scholar
  6. 6.
    Gori, A., Tincati, C., Rizzardini, G., et al., Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis, J. Clin. Microbiol., 2008, vol. 46, p. 757.CrossRefGoogle Scholar
  7. 7.
    Paiardini, M., Frank, I., Pandrea, I., et al., Mucosal immune dysfunction in AIDS pathogenesis, AIDS, 2008, vol. 10, p. 36.Google Scholar
  8. 8.
    Khasanova, G.R., Anokhin, V.A., Bikkinina, O.I., et al., Intestinal endotoxin as a potential inducer of systemic inflammatory response under HIV infection, Prakt. Med., 2012, no. 1, p. 52.Google Scholar
  9. 9.
    Bikkinina, O.I., Khasanova, G.R., and Nagimova, F.I., Effectiveness of therapy for the anemia of chronic disease using “anti-endotoxin component” in HIV patients, Vestn. Sovrem. Klin. Med., 2013, vol. 6, no. 3, p. 93.Google Scholar

Copyright information

© Pleiades Publishing, Inc. 2015

Authors and Affiliations

  • I. A. Anikhovskaya
    • 1
    • 3
  • A. A. Kubatiev
    • 1
  • G. R. Khasanova
    • 2
  • M. Yu. Yakovlev
    • 1
    • 4
    Email author
  1. 1.Research Institute of General Pathology and PathophysiologyRussian Academy of SciencesMoscowRussia
  2. 2.Kazan State Medical University and Republican Center for AIDS and Infectious Disease Prevention and ControlMinistry of Health of the Republic of TatarstanKazan, TatarstanRussia
  3. 3.Institute of General and Clinical Pathology, Clinical Diagnostic SocietyRussian Academy of Natural SciencesMoscowRussia
  4. 4.Russian State Medical UniversityMoscowRussia

Personalised recommendations